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Abstract
Background: The somatosensory phenotype of Chinese temporomandibular disorders (TMD) patients is not
sufficiently studied with the use of contemporary techniques and guidelines.
Methods: A standardized quantitative sensory testing (QST) battery consisting of 13 parameters with a stringent
statistical protocol developed by the German Research Network on Neuropathic Pain was performed over the most
painful and corresponding contralateral sites as well as the right hand of 40 Chinese patients with TMD and pain
classified according to the Diagnostic Criteria for TMD (DC/TMD). The same QST protocol was performed bilaterally
over the infraorbital, mental, and hand regions of 70 age- and gender-stratified healthy Chinese controls. Z-scores
and loss/gain scores were computed for each TMD patient.
Results: For patients, 82.5 % had somatosensory abnormalities in the painful facial region, while 60.0 % had abnormalities
confined to the right hand. The most frequent abnormalities were somatosensory gain to pinprick (35.0 %) and pressure
(35.0 %) stimuli, somatosensory loss to pinprick (25.0 %), cold (22.5 %), and heat (15.0 %) nociceptive stimuli. The most
frequent loss/gain score was L0G2 (no somatosensory loss combined with a gain of mechanical somatosensory function)
for both the facial (40.0 %) and hand (27.5 %) regions. Involving side-to-side differences in the evaluation increased the
diagnostic sensitivity by 2.5–25.0 % across different parameters.
Conclusions: Somatosensory abnormalities were commonly detected in Chinese TMD pain patients both within and
outside the primary painful region, strongly indicating disturbances in the central processing of somatosensory stimuli.
The individual variations in somatosensory abnormalities indicate a possible need for development of individualized TMD
pain management.
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Background
Temporomandibular disorders (TMD) pain is not only
of major importance for individuals but also constitutes
a major public health problem with a large impact on
health-related expenses [1]. Despite the impact of TMD
pain on the individual person and the community, stud-
ies indicate that patients with TMD pain are not suffi-
ciently and adequately diagnosed or treated [2]. It is an
open question whether the classification of pain
syndromes based solely on the etiology is optimal, or
whether it might be preferable to classify pain conditions
on the basis of symptoms and signs [3, 4] or on patterns
of somatosensory abnormalities [5, 6]. The individual
pattern of somatosensory abnormalities at the affected
and remote body areas reflects altered somatosensory
functions. This may open a window to understand the
mechanisms underlying pain.
Somatosensory sensitivity can be measured by quanti-
tative sensory testing (QST) [7–12]. The German Re-
search Network on Neuropathic Pain (DFNS) has
established a standardized QST protocol for examination
and data analysis [7, 13]. The DFNS introduced somato-
sensory profiles and the “loss/gain” coding system based
on Z-scores computed using the means and standard
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deviations of reference data, and pain patients could be
defined as different thermal and mechanical somatosen-
sory abnormal groups according the coding system [7].
So far, just few studies have assessed somatosensory sen-
sitivity in patients with TMD pain using the full stan-
dardized QST protocol. In one study, 21 patients with
myofascial TMD pain were divided with respect to the
tender point into an insensitive subgroup resembling
healthy subjects and a sensitive subgroup resembling
fibromyalgia syndrome patients’ QST profile [14]. The
sensitive subgroup showed more expanded pain areas
and generalized changes in pain perception over the
cheek, trapezius, and hand dorsum in contrast to the in-
sensitive patients with more localized changes [14].
Kothari et al. assessed somatosensory function at the
temporomandibular joint (TMJ) and conditioned pain
modulation of TMD pain patients with compared to
healthy controls [15]. The results indicated that most
(85.3 %) of the patients exhibited at least 1 or more som-
atosensory abnormalities at the painful TMJ with som-
atosensory gain with regard to pressure and punctate
mechanical pain stimuli, and somatosensory loss with
regard to mechanical detection and vibration detection
stimuli [15]. The previous studies investigated the som-
atosensory changes of primarily Caucasian TMD pain
patients, and showed that part of the patients had abnor-
mal somatosensory function at the painful TMJ and in
extra-trigeminal regions. However, the Chinese or east-
ern Asian populations are the biggest in the world but
remain understudied using the contemporary and stan-
dardized QST protocols [7].
The aim of this study was to expand the description of
the clinical phenotype and to evaluate somatosensory
abnormalities in painful facial and remote regions of
Chinese patients with TMD pain diagnosed with repro-
ducible and validated criteria according to the inter-
national Diagnostic Criteria for TMD [16]. The TMD
pain patients were compared with an age-, gender- and





Healthy Chinese participants between 18 and 70 years of
age were recruited through advertisement in the commu-
nity. Exclusion criteria were: ongoing pain or reported
chronic pain in the last 6 months; serious systemic disease
or previous radiotherapy or chemotherapy; intake of
medicine affecting the central nervous system; fibromyal-
gia syndrome, or self-reported psychogenic illness. Indi-
viduals’ medical history was checked by a clinical dentist
and one TMD specialist performed DC/TMD on all the
participants to exclude TMD patients. One hundred and
three healthy Chinese volunteers responded to the adver-
tisement. Finally, 70 healthy participants between 24 and
69 years of age (42.3 ± 12.5 years), 36 females (43.1 ±
12.8 years) and 34 males (41.5 ± 12.3 years) met the cri-
teria, were recruited, and finished the whole test.
TMD pain patients
From 2012 to 2014, Chinese individuals with a primary
complaint of pain in the orofacial region were recruited
from the Center for TMD and Orofacial Pain of Peking
University School and Hospital of Stomatology, China.
All patients were investigated and diagnosed (myalgia or
arthralgia) by one TMD specialist who had received ex-
tensive training and calibration in the use of the Diag-
nostic Criteria for Temporomandibular Disorders (DC/
TMD) [16]. Pain intensity just before the test was rated
by the patients on a 0–10 cm visual analogue scale (0
= “no pain”, 10 = “most pain imaginable”). Exclusion cri-
teria were: serious systemic disease or previous radio-
therapy or chemotherapy; intake of medicine affecting
the central nervous system; fibromyalgia syndrome,
headache, or any therapy during the 2 weeks prior to in-
clusion, bilateral TMD pain. Of the 960 Chinese pa-
tients, most were excluded either because they suffered
from additional painful conditions or multiple disorders
affecting the nervous system, they were not interested in
the study, or their records were incomplete. Forty pa-
tients with TMD pain (8 males, 32 females) aged 20–77
years (44.3 ± 15.5 years, ≤40 year n = 19, >40 year n = 21)
were finally recruited and finished the test. The patients
were diagnosed using DC/TMD as having myalgia (n =
30, temporalis and masseter muscle origin) and arthral-
gia without intra-articular joint disorders (n = 10). The
self-reported TMD peak pain intensity before the test on
the 0–10 cm scale was 2.9 ± 1.7 cm. The range of self-
reported pain duration was 14.5 ± 21.1 months (0.25–
100 months, <3 months n = 11, ≥3 months n = 29). The
psychological status of patients was evaluated using the
SCL-90 scale with 9 domains [17].
The study adhered to the Declaration of Helsinki II,
was approved by the local Ethics Committee (PKUS-
SIRB-2013012), and all participants gave written in-
formed consent.
Quantitative Sensory Testing (QST) protocol
The standardized QST battery developed by DFNS and
modified for the trigeminal region was used in this study
[8–12, 15]. All QST measures were performed in a quiet
room at 21–23 °C. The QST protocol consists of 7 tests
measuring a total of 13 thermal and mechanical parame-
ters: A. Thermal testing comprises detection and pain
thresholds for cold, warm, and hot stimuli (mediated by
C- and A-delta fibers): cold detection threshold (CDT);
warm detection threshold (WDT); number of paradoxical
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heat sensations (PHS) during the thermal sensory limen
procedure (TSL) for alternating warm and cold stimuli;
cold pain threshold (CPT); and heat pain threshold
(HPT). B. Mechanical detection threshold (MDT) tests for
A-beta fiber function using von Frey filaments. C. Mech-
anical pain threshold (MPT) tests for A-delta fiber-
mediated hyper- or hypo-algesia to pinprick stimuli. D.
Stimulus–response-functions: mechanical pain sensitivity
(MPS) to pinprick stimuli and dynamic mechanical allody-
nia (DMA) assessment of A-delta fiber-mediated sensitiv-
ity to sharp stimuli (pinprick), as well as A-beta fiber-
mediated pain sensitivity to stroking light touch (CW, cot-
ton wisp; QT, cotton-wool tip; BR, brush). E. Wind-up ra-
tio (WUR) compares the numerical ratings within three
trials of a single pinprick stimulus (a) with a series (b) of
10 repetitive pinprick stimuli to calculate WUR as the ra-
tio b/a. F. Vibration detection threshold (VDT) tests for
A-beta fiber function using a Rydel–Seiffer 64-Hz tuning
fork. G. Pressure pain threshold (PPT) is the only test for
deep-pain sensitivity, most probably mediated by muscle
C- and A-delta fibers [13, 15]. The investigator in this
study was carefully instructed and trained according to
the latest guidelines [9]. The full QST protocol took ap-
proximately 30 min per test site (Fig. 1). All the tests were
performed following the sequence suggested by DFNS.
In the present study, three skin regions of TMD
pain patients were examined: the painful facial region,
the mirror region on the contralateral side, and the
dorsum of the right hand. The contralateral sites were
tested first, followed by the painful sites. Healthy par-
ticipants were investigated bilaterally on six skin re-
gions: the infraorbital regions (V2), the mental
regions (V3), and the dorsum of the hands. A stand-
ard set of instructions lasting ~1 min was read to the
Fig. 1 The battery of quantitative sensory testing (QST). The standardized QST protocol consists of 7 tests (A-G) to assess the 13 parameters. a
Thermal testing comprises detection and pain thresholds for cold, warm and hot stimuli (C and A-delta fiber mediated): cold detection threshold
(CDT), warm detection threshold (WDT), cold pain threshold (CPT) and heat pain threshold (HPT) with inter-stimulus interval of 20 s; number of
paradoxical heat sensations (PHS) during the thermal sensory limen procedure (TSL) for alternating warm and cold stimuli. b Mechanical detection
threshold (MDT) test using von Frey-filaments (A-beta fiber mediated) with inter-stimulus interval of ~10 s. c Mechanical pain threshold (MPT) for
pinprick stimuli (mediated by A-delta fiber) assessing hyper- or hypoalgesia with inter-stimulus interval of ~10 s. d Stimulus–response-functions:
mechanical pain sensitivity (MPS) assess A-delta fiber mediated sensitivity to sharp stimuli (pinprick) and dynamic mechanical allodynia (DMA)
assess A-beta fiber mediated pain sensitivity to stroking light touch (CW = cotton wisp; QT = cotton wool tip; BR = brush), with inter-stimulus
interval of ~10 s. e Wind-up ratio (WUR) compares the numerical ratings within three trains of a single pinprick stimulus (a) with a series (b) of 10
repetitive pinprick stimuli to calculate WUR as the ratio: b/a, with ~10 s intervals between single and series stimulus. f Vibration detection
threshold (VDT) tests for A-beta fiber function using a Rydel–Seiffer 64 Hz tuning fork with intervals of ~10 s. g Pressure pain threshold (PPT) is
the only test for deep pain sensitivity, most probably mediated by muscle C- and A-delta fibers, with inter-stimulus interval of 60 s.
ISI = Inter-Stimulus-Interval, In = Instruction
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participants for each different modality just before the
beginning of each test, i.e. there were 1-min intervals
between tests [10–13].
Thermal thresholds and thermal sensory limen
Thermal testing was performed using Medoc Pathway
(Medoc Ltd, Israel) with an Advanced Thermal
Stimulator (30 mm × 30 mm) [10–13]. CDT, WDT,
CPT, and HPT were measured in triplicate [10–13].
For the TSL, the temperature first went up, and the
participants pressed a button when they perceived a
change [10–13]. The number of PHSs during this
procedure was recorded [10–13]. Baseline temperature
was set at 32 °C for all thermal testing, ramped stim-
uli of 1 °C/s was used, cutoff temperatures were set
at 0 and 50 °C [10–13].
Mechanical detection threshold
The MDT was measured with a standard set of
Semmes-Weinstein monofilaments (Touch Test TM
Sensory Evaluator, North Coast Medical, Inc., Morgan
Hill, CA) with 20 different diameters [10–12, 15]. Five
repeated threshold measurements were made, each by
applying a series of ascending and descending stimulus
intensities; the final threshold was the geometric mean
of the five series [10–13].
Mechanical pain threshold, mechanical pain sensitivity to
pinprick stimuli, dynamic mechanical allodynia, and wind-
up ratio for repetitive pinprick stimuli
Weighted pinprick stimuli were delivered with seven
custom-made punctate mechanical stimulators with
fixed stimulus intensities (flat contact area 0.2 mm in
diameter) that exerted forces of 8 to 512mN to deter-
mine the MPT [10–13]. The method of limits, which
was used to determine the MDT, was also used to deter-
mine the MPT [10–13].
MPS and DMA were evaluated using two sets of in-
struments in a stimulus–response assessment [7, 13]. To
determine MPS, 7 weighted pinprick stimulators were
used (as for MPT). Three tactile stimulators were used
to determine DMA: a cotton wisp (~3mN), a cotton-
wool tip (Q-tip, ~100mN) attached to a flexible handle,
and a disposable toothbrush (Top Dent®, Meda AB,
Solna, Sweden, ~200-400mN) [10–12, 15]. A series of 10
measurements was made three times, each with the 10
stimulators (7 pinpricks and 3 tactile stimulators) ap-
plied in a different order, as specified in the DFNS
protocol [10–13]. For each of the resulting 30 stimuli,
the participant chose a pain rating on a 0 to 100 scale
with the endpoints ‘0’ indicating “no pain” and ‘100’ in-
dicating “most intense pain imaginable”.
To measure the WUR for repetitive pinprick stimuli,
the perceived magnitude of a train of 10 pinprick stimuli
repeated at 1 Hz was divided by that of a single pinprick
stimulus with the same force [10, 13]. The WUR test
was repeated three times [10–13, 15].
Vibration detection threshold
The vibration detection threshold (VDT) was measured
tuning fork (64 Hz, 8/8 scale) [7, 13]. VDT was per-
formed on bony prominences bilaterally for each partici-
pant: the zygomatic process, the lower edge of the
mandible, and the ulnar styloid process. The participant
indicated when the vibration could no longer be sensed
on a 9-point (0–8) scale [10–13, 15]. The test was re-
peated three times.
Pressure pain threshold
The pressure pain threshold (PPT) was measured using
a computerized pressure algometer (Medoc AlgoMed,
Israel) [10–13, 15]. PPT was measured on the painful
site, the corresponding contralateral site, and the right
thenar muscle of patients; and on the temporalis, mas-
seter, and thenar muscles bilaterally of healthy partici-
pants; both with a constant application rate of 30kPa/s
[10–13, 15]. The test was repeated three times.
Data analysis and statistics
All absolute QST scores are presented as mean ± SD.
Cold and heat pain thresholds as well as vibration
thresholds were normally distributed. All other parame-
ters were normally distributed only after log-
transformation. There was no PHS or DMA in the
healthy group. For the remaining 11 parameters, the
data for healthy participants were considered as refer-
ence values. As our previous study showed, somatosen-
sory data from the 70 healthy participants exhibited
significant gender, age, and region differences [11, 15].
The data were stratified for age group (younger
≤40 years, n = 32; older >40 years, n = 38), gender, and
region (infraorbital, mental, and hand) to allow a more
detailed analysis of the somatosensory abnormalities of
TMD pain patients (absolute data in Additional file 1:
Table S1, side-to-side differences data in Additional file
1: Table S2).
Z-transformation of QST data
A z-transformation was performed for each variable.
The sign of the resulting z-score was adjusted in such a
way that those above >0 indicated a gain-of-function
when the participant was more sensitive to the stimuli
compared with controls (hyperesthesia, hyperalgesia,
and allodynia), while z-scores <0 indicated a loss-of-
function referring to a lower sensitivity (hypoesthesia
and hypoalgesia) [7, 18]. A z-score of 0 ± 1.96 represents
the range that can be expected to include 95 % of the
control data [7, 18]. To compare individual QST data
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from patients with the mean reference range of the same
region (V2, V3, or hand) of age- and gender-matched
controls, the patient data were z-transformed for each
single variable in the same way, using the transformation
parameters of the reference group. The individual pain
site z-scores were calculated as (meanreference group ‐ indi-
vidual value)/SDreference group [4, 10]. Z-scores >1.96 and
< −1.96 indicate values outside of the 95 % CI of the ref-
erence group data. Such values were considered to be
“absolute abnormalities” [7]. Also, the side-to-side differ-
ences of each QST parameter from patients were com-
pared with the 95 % CI of the side-to-side differences of
the reference group [7]. If the side-to-side differences
were larger than the upper limit of the 95 % CI of the
reference group, the value was considered to be a “rela-
tive abnormality” [7]. In accordance with Maier et al. [7],
the assessment of frequencies of loss and gain of som-
atosensory function included a combination of absolute
and relative (side-to-side) abnormalities (the basis of the
loss/gain coding system).
Assessment of somatosensory loss and gain of function
The loss/gain coding system was applied [7, 18]. The
loss/gain score combines a score of somatosensory
loss of function (L0, L1, L2, or L3) with a score of
somatosensory gain of function (G0, G1, G2, or G3)
[7, 18]. The number after the letter L or G indicates
whether the abnormality is related to the thermal
modalities alone (1), the mechanical modalities alone
(2), or mixed (3) (thermal and mechanical). If mea-
sures of thermal and/or mechanical detection (CDT,
WDT, TSL, MDT, or VDT) were abnormal on the
affected side in comparison with the reference data
(“absolute abnormality”) or if abnormally large side-
to-side differences were detected (“relative abnormal-
ity”), it was recorded as one of the following: L1,
isolated loss of small fiber function (if abnormal
thermal detection thresholds [CDT, TSL, or WDT]
alone); L2, isolated loss of large fiber function (if ab-
normal mechanical detection thresholds [MDT or
VDT] alone); or L3, mixed loss of function (if loss
of both small and large fiber function) [7, 18]. Like-
wise for somatosensory gain, thermal hyperalgesia
(G1) was recorded if gain-of-function in cold or heat
pain thresholds (CPT or HPT) were found (absolute
or relative abnormality). Mechanical hyperalgesia
(G2) was recorded if gain-of-function (absolute or
relative abnormality) was detected for MPT, MPS, or
PPT, or if the DMA score exceeded 0. Mixed gain
(G3) was recorded in individuals with gain of both
thermal and mechanical somatosensory function. L0
was scored if no loss of somatosensory function was
presented, and G0 if no gain of somatosensory func-
tion was detected.
Statistics
All statistical calculations were performed using SPSS
17.0 for Windows (IBM, Armonk, New York City, NY).
The distribution of frequencies of loss and gain of som-
atosensory function at the painful site and hand between
groups according to loss/gain coding was evaluated with
χ2 tests with Bonferroni adjustments for multiple com-
parisons. Values of P <0.01 were considered statistically
significant.
Results
Somatosensory abnormalities in healthy participants
As expected due to natural variation, a few abnormalities
were found in the reference group (mean across parame-
ters for somatosensory loss 4.0 ± 2.0 % and for somato-
sensory gain 1.1 ± 2.2 %) (Table 1) [7, 18].
Absolute abnormalities of QST z-scores and side-to-side
differences in TMD pain patients
There was no PHS or DMA in the patient group. The
most frequent somatosensory absolute abnormalities at
the painful site of the TMD pain group was (in order of
frequency): somatosensory gain with regard to MPS,
PPT, WUR, and WDT; and somatosensory loss with re-
gard to CPT, HPT, MDT, MPT, CDT, TSL, VDT, and
WDT (Table 1, Fig. 2).
The frequencies of abnormal values in the painful re-
gion for each QST parameter in 40 TMD pain patients
are shown in Fig. 3. For all non-nociceptive detection
thresholds except for WDT, only sensory loss was de-
tected according to the absolute data (roughly 5–10 %
across different parameters) (Table 1). Side-to-side dif-
ferences identified additional patients with relative sen-
sory loss to non-nociceptive stimuli (for different
parameters between 2.5 and 5.0 % additional pa-
tients), and relative sensory gain were detected for
the non-nociceptive parameters (for different parame-
ters between 2.5 and 12.5 % additional patients) (Fig. 3
and Table 2). For the nociceptive parameters, both
sensory loss (hypoalgesia) (10.0–15.0 %) and sensory
gain (hyperalgesia) (7.5–35.0 %) were found in the ab-
solute data (Table 1 and Fig. 3). The inclusion of ab-
normal side-to-side differences increased both the
frequency of patients with loss (5.0–25.0 % additional
patients with hypoalgesia) and with gain (5.0–10.0 %
additional patients with hyperalgesia) in nociceptive
function (Fig. 3 and Table 2).
Somatosensory abnormalities of TMD pain patients
according to the loss/gain coding system
The distribution of participants in each group according
to the loss/gain coding system is shown in Table 3. Only
17.5 % of the pain patients had no somatosensory abnor-
malities, compared with 68.8 % of the reference group (P
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<0.001). L0G2 (no somatosensory loss with gain of
mechanical somatosensory function) was the most fre-
quent coding in the TMD group (40.0 %), which was sig-
nificantly different from the reference group (10.2 %) (P
<0.001). The cumulative proportion of somatosensory
loss without any gain (L1G0, L2G0, and L3G0) was
12.5 % in the TMD group and 19.7 % in the reference
group (P = 0.399). The cumulative proportion of partici-
pants presenting with somatosensory gain without any
loss (L0G1, L0G2, and L0G3) was higher in the TMD
group (50.0 %) than in the reference group (10.2 %) (P
<0.001). The cumulative proportion of the groups
Table 1 Mean and standard deviation (SD) of the quantitative sensory testing (QST) parameters from the infraorbital, mental, and
hand regions before and after z-transformation in the reference group and from the painful site in the temporomandibular disorders
(TMD) patients
Reference group (420 sitesa) TMD patient group (40 sites)







Infraorbital Mental Hand n (%) n (%) n (%) n (%)
CDT −0.90(0.46) −0.93(0.38) −1.72(1.04) 0.00(1.00) 22(5.2 %) 0(0.0 %) −0.84(0.34) 0.10(1.06) 2(5.0 %) 0(0.0 %)
WDT 1.16(0.35) 1.34(0.57) 2.50(1.25) 0.00(1.00) 21(5.0 %) 0(0.0 %) 1.14(0.46) 0.31(1.07) 1(2.5 %) 1(2.5 %)
TSL 2.80(1.38) 2.68(1.30) 4.95(2.55) 0.00(1.00) 21(5.0 %) 0(0.0 %) 2.41(1.20) 0.02(1.11) 2(5.0 %) 0(0.0 %)
CPT 23.82(5.86) 23.51(6.81) 23.43(6.92) 0.00(1.00) 20(4.7 %) 0(0.0 %) 22.20(7.68) −0.29(1.14) 6(15.0 %) 0(0.0 %)
HPT 37.61(2.75) 38.99(3.19) 40.52(3.55) 0.00(1.00) 16(3.8 %) 0(0.0 %) 38.71(3.32) −0.07(1.10) 4(10.0 %) 0(0.0 %)
MDT 0.13(0.08) 0.12(0.09) 3.05(3.37) 0.00(1.00) 23(5.5 %) 0(0.0 %) 0.15(0.25) −1.42(8.12) 4(10.0 %) 0(0.0 %)
MPT 89.19(66.94) 78.57(73.68) 155.33(110.58) 0.00(1.00) 22(5.2 %) 0(0.0 %) 78.46(86.08) −0.14(1.58) 4(10.0 %) 0(0.0 %)
MPS 2.08(1.53) 2.23(1.72) 1.27(1.30) 0.00(1.00) 0(0.0 %) 24(5.7 %) 4.95(4.64) 1.69(3.21) 0(0.0 %) 14(35.0 %)
WUR 2.99(1.90) 3.02(2.10) 2.90(1.88) 0.00(1.00) 0(0.0 %) 25(5.9 %) 3.40(2.01) 0.26(1.06) 0(0.0 %) 3(7.5 %)
VDT 7.36(0.48) 7.49(0.55) 7.65(0.43) 0.00(1.00) 19(4.5 %) 0(0.0 %) 7.63(0.41) 0.22(1.02) 2(5.0 %) 0(0.0 %)









The individual z-scores for each parameter were calculated as (meanreference group ‐ individual value)/SDreference group with regard to data stratified according to
gender, age, and region [10, 13]. Z-scores above 1.96 and below −1.96 indicate values outside of the 95 % confidence interval (CI) of the reference group data.
Such values were considered to be absolute abnormalities
CDT cold detection threshold, WDT warmth detection threshold, TSL thermal sensory limen, PHS paradoxical heat sensation, CPT cold pain threshold, HPT heat
pain threshold, MDT mechanical detection threshold, MPT mechanical pain threshold, MPS mechanical pain sensitivity, DMA dynamic mechanical allodynia, WUR
windup ratio, VDT vibration detection threshold, PPT pressure pain threshold
a The infraorbital, mental and hand regions were measured bilaterally in each healthy participant, 420 sites were tested for 70 participants, and 140 test sites for
each region
Fig. 2 Examples of somatosensory z-score profiles of 2 patients with painful temporomandibular disorders indicating abnormalities involving different
peripheral or central pain mechanisms [10–13]. Open symbols indicate patient A (loss of function to tactile, pinprick, and thermal non-nociceptive
stimuli), and closed symbols indicate patient B (gain of function to painful pinprick and pressure stimuli). The zone between the two lines (−1.96 < z <
1.96) is the normal range based on the healthy material. CDT: cold detection threshold; WDT: warmth detection threshold; TSL: thermal sensory limen;
CPT: cold pain threshold; HPT: heat pain threshold; MDT: mechanical detection threshold; MPT: mechanical pain threshold; MPS: mechanical pain
sensitivity; WUR: windup ratio; VDT: vibration detection threshold; PPT: pressure pain threshold
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showing mixed loss and gain (L1G1, L1G2, L1G3, L2G1,
L2G2, L2G3, L3G1, L3G2, or L3G3) was higher in the
TMD group (20.0 %) than in the reference group (1.2 %)
(P <0.001) (Table 3).
Somatosensory abnormalities in the hand region
The individual hand dorsum z-scores for each modality
based on the means and SDs of the healthy reference
data showed that 25.0 % of patients had gain of somato-
sensory function for MPS, 20.0 % had gain of function
for WUR; 12.5 % had somatosensory loss for MPT,
10.0 % had loss of function for CDT, WDT, and PPT,
and 7.5 % had loss of function for TSL and CPT (Add-
itional file 1: Table S3).
The distribution of the participants in each group ac-
cording to the loss/gain coding system is shown in Add-
itional file 1: Table S4. Forty percent of the TMD pain
patients had no somatosensory abnormalities in the
hand region, compared with 75.7 % of the reference
group (P <0.001). L0G2 was the most frequent coding in
the TMD pain group (27.5 %), which was markedly
higher than in the healthy group (4.3 %) (P = 0.001). The
Fig. 3 Absolute and relative abnormalities for temporomandibular disorder patients in the painful area. Values outside the 95 % confidence
intervals of the healthy reference data are considered to be absolute abnormalities, and differences of the affected side versus the unaffected
side outside the 95 % confidence intervals of such differences of the healthy reference data are considered to be relative abnormalities. The y-axis
shows the percentage of patients (n = 40), with positive sensory signs plotted upwards and negative sensory signs plotted downwards. CDT: cold
detection threshold; WDT: warmth detection threshold; TSL: thermal sensory limen; CPT: cold pain threshold; HPT: heat pain threshold; MDT:
mechanical detection threshold; MPT: mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: windup ratio; VDT: vibration detection
threshold; PPT: pressure pain threshold
Table 2 Mean values and standard deviation (SD) of absolute values of side-to-side differences at the painful sites in the temporo-
mandibular disorders (TMD) patients and the healthy reference group

















CDT 0.23(0.20) 0.27 0.20(0.22) 0.26 0.44(0.53) 0.57 0.19(0.16) 3(7.5 %)
WDT 0.23(0.22) 0.28 0.32(0.31) 0.39 0.86(0.80) 1.05 0.19(0.19) 1(2.5 %)
TSL 0.64(0.49) 0.76 0.43(0.38) 0.52 1.32(1.52) 1.68 0.59(0.67) 6(15.0 %)
CPT 1.86(1.72) 2.27 1.33(1.50) 1.69 2.11(2.11) 2.62 2.84(3.97) 7(17.5 %)
HPT 1.43(1.63) 1.82 1.16(1.07) 1.42 1.12(0.93) 1.35 1.14(1.08) 4(10.0 %)
MDT 0.05(0.07) 0.06 0.04(0.08) 0.06 2.35(2.88) 3.04 0.07(0.19) 5(12.5 %)
MPT 33.21(37.38) 42.12 27.52(50.91) 39.66 51.64(49.74) 63.50 23.74(40.88) 0(0.0 %)
MPS 0.60(0.90) 0.82 0.73(0.95) 0.95 0.50(0.74) 0.68 1.90(2.38) 10(25.0 %)
WUR 1.00(1.27) 1.30 1.02(1.28) 1.32 0.91(1.02) 1.16 0.70(0.86) 0(0.0 %)
VDT 0.24(0.22) 0.29 0.16(0.18) 0.21 0.18(0.18) 0.22 0.24(0.24) 2(5.0 %)
PPT 24.64(23.85) 30.33 25.71(21.62) 30.87 49.09(41.50) 58.99 38.19(38.41) 3(7.5 %)
CDT cold detection threshold, WDT warmth detection threshold, TSL thermal sensory limen, PHS paradoxical heat sensation, CPT cold pain threshold, HPT heat
pain threshold, MDT mechanical detection threshold, MPT mechanical pain threshold, MPS mechanical pain sensitivity, DMA dynamic mechanical allodynia, WUR
windup ratio, VDT vibration detection threshold, PPT pressure pain threshold, CI confidence interval
The upper limit of the 95 % CI (95 % CIup) of the side-to-side differences in the reference group is also given as it was used in the evaluation of relative abnormal-
ities for the LossGain scores. The abnormal frequencies of TMD patients were evaluated by age, gender and site stratified data
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cumulative proportion of somatosensory loss without
any gain (L1G0, L2G0, and L3G0) was 15.0 % in the TMD
group and 17.1 % in the reference group (P = 0.771). The
cumulative proportion of participants presenting with som-
atosensory gain at the hand site without any loss (L0G1,
L0G2, and L0G3) was higher in the TMD group (30.0 %)
than in the reference group (4.3 %) (P <0.001). The cumula-
tive proportion in the groups showing mixed loss and gain
(L1G1, L1G2, L1G3, L2G1, L2G2, L2G3, L3G1, L3G2, or
L3G3) in the hand region was higher in the TMD group
(15.0 %) than in the reference group (2.9 %) (P = 0.026)
(Additional file 1: Table S4).
Psychological status of patients
Twelve of 40 patients (30 %) had psychological abnor-
malities compared with reference data [17]. Somatization
was the most frequent psychological changes (25 %),
Paranoid ideation was the lowest (10 %) (Additional file
1: Table 4).
Table 3 Loss and gain distribution in the painful region in temporomandibular disorder (TMD) patients and the healthy reference
group
Loss Gain All
G0 (None) G1 (Thermal) G2 (Mechanical) G3 (Both)
TMD patients (40 sites)
L0 (None) 7(17.5 %) 1(2.5 %) 16(40.0 %) 3(7.5 %) 27(67.5 %)
L1 (Thermal) 2(5.0 %) 0(0.0 %) 3(7.5 %) 0(0.0 %) 5(12.5 %)
L2 (Mechanical) 2(5.0 %) 0(0.0 %) 3(7.5 %) 0(0.0 %) 5(12.5 %)
L3 (Both) 1(2.5 %) 0(0.0 %) 1(2.5 %) 1(2.5 %) 3(7.5 %)
All 12(30.0 %) 1(2.5 %) 23(57.5 %) 4(10.0 %) 40(100 %)
Reference group (420 sites)
L0 (None) 289(68.8 %) 0(0.0 %) 43(10.2 %) 0(0.0 %) 332(79.0 %)
L1 (Thermal) 42(10.0 %) 0(0.0 %) 4(1.0 %) 0(0.0 %) 46(11.0 %)
L2 (Mechanical) 38(9.0 %) 0(0.0 %) 1(0.2 %) 0(0.0 %) 39(9.3 %)
L3 (Both) 3(0.7 %) 0(0.0 %) 0(0.0 %) 0(0.0 %) 3(0.7 %)
All 372(88.6 %) 0(0.0 %) 48(11.4 %) 0(0.0 %) 70(100 %)
Sensory abnormality coding system [7]: hypoesthesia to thermal stimuli (loss of detection in the cold or warm detection threshold) was coded as L1,
and hypoesthesia to mechanical stimuli (loss of detection in mechanical or vibration detection threshold) as L2. Signs of hyperalgesia to thermal
stimuli (gain-of-function in heat or cold pain threshold) were coded as G1, and hyperalgesia to mechanical stimuli (gain-of-function in mechanical
pain threshold or sensitivity, dynamic mechanical allodynia, or pressure pain threshold) as G2. When both thermal and mechanical abnormalities
were present, L3 or G3 were defined. Normal values were coded as zero
Table 4 Psychological status of Chinese TMD pain patients
Categories na/(%) Patient (mean ± SD) Control (mean ± SD)
Somatization 10 (25 %) 1.97 ± 0.67 1.37 ± 0.48
Obsessive compulsive 7 (17.5 %) 2.00 ± 0.84 1.62 ± 0.58
Interpersonal sensitivity 7 (17.5 %) 1.79 ± 0.72 1.65 ± 0.51
Depression 7 (17.5 %) 1.90 ± 0.77 1.5 ± 0.59
Anxiety 8 (20 %) 1.76 ± 0.74 1.39 ± 0.43
Anger and hostility 5 (12.5 %) 1.76 ± 0.75 1.48 ± 0.56
Phobic anxiety 7 (17.5 %) 1.52 ± 0.66 1.23 ± 0.41
Paranoid ideation 4 (10 %) 1.64 ± 0.62 1.43 ± 0.57
Psychoticism 5 (12.5 %) 1.57 ± 0.50 1.29 ± 0.42
Average 6.7 (16.7 %)
The psychological status of patients was evaluated using the SCL-90 scale [17]. an = the number of patients’ score outside the normal range of reference data
(mean ± 1.96 SD)
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Discussion
In this study, we applied the full battery of standardized
QST consisting of 13 parameters to patients with TMD
pain and age-, gender-, and region-stratified healthy par-
ticipants. The main finding was that 82.5 % of the pa-
tients presented somatosensory abnormalities in terms
of loss or gain of somatosensory function in the painful
facial regions, while the frequency of abnormality in the
right hand region was 60.0 %, compared with 31.2 % in
facial and 24.3 % in hand regions of the reference popu-
lation. Mechanical tests were more often associated with
abnormalities than thermal tests (Tables 1 and 3). The
most frequent loss/gain score encountered was L0G2
(no somatosensory loss combined with gain of mechan-
ical somatosensory function). Interestingly, this result
corresponds with the score most frequently found in pa-
tients with trigeminal neuropathic pain and atypical
odontalgia in a mainly Caucasian population [7, 18], but
was much less common in other non-trigeminal neuro-
pathic pain conditions [7]. Some TMD pain patients in
the present study did not show somatosensory abnor-
malities during QST at the standard testing areas. This
phenomenon could have been due to the standardization
of test sites in our study. QST was performed over the
most painful sites of the jaw muscles or the temporo-
mandibular joints in all patients, while pain in TMD can
originate from 12 specified test sites in the temporalis
and masseter muscles or temporomandibular joint per
side [16]. Only a few studies have demonstrated somato-
sensory abnormalities in TMD patients [14, 19]. The im-
portant strengths of the present study were the
standardized evaluation of the phenotypes in terms of
somatosensory abnormalities in Chinese TMD pain pa-
tients using loss and gain scores based on a comprehen-
sive QST protocol and Z-score transformation [9],
Comparing indirectly between the results of the present
study in a Chinese population and earlier studies in a
mainly Caucasian patient population, it seems that gain
of mechanical function (mechanical hyperalgesia) is the
most frequent somatosensory abnormality for both
Chinese and Caucasian TMD patients [14, 15].
Somatosensory abnormalities according to the loss/gain
system
The loss/gain coding system includes the evaluation of
absolute (score outside 95 % CI of reference) and relative
(side-to-side difference outside 95 % CI of reference) ab-
normalities [7, 18]. It has been suggested that using ab-
solute abnormalities alone may be too conservative for
detecting somatosensory abnormalities, mainly due to
the large inter-individual variation in somatosensory sen-
sitivity [7]. Involving the side-to-side difference in the
evaluation increased the diagnostic sensitivity by 2.5–
25.0 % across different parameters in our study (Fig. 3),
and did not change their pattern, which is in line with
an earlier study [7].
Like the studies conducted by Maier et al. and Baad-
Hansen et al. [7, 18], we also detected some somatosen-
sory abnormalities in the healthy group, a total of 31.2 %
showing one or more values outside the 95 % CI (Table 3).
This frequency may seem high, but is actually lower than
would be expected based on simple calculation of the
probability of a healthy person having at least 1 of 11
values outside the 95 % CI (1–0.9511 = 43.1 %) [18]. The
standardized QST and loss/gain coding system enables
standardized evaluation of somatosensory changes in con-
ditions and diseases with sensory disorders.
Pfau’s study demonstrated differences comparing a
TMD patient group and control group for CPT, PPT,
MPT, MPS and MDT with TMD patients being more
sensitive to painful stimuli, but less sensitive to tactile
stimulation on a group level [14]. In Kothari’s study, a
total of 85.3 % of the TMD patients exhibited one or
more somatosensory abnormalities at the most painful
site. The most frequent somatosensory abnormalities in
terms of gain of function were hyperalgesia to blunt
pressure, hyperalgesia to pinprick-evoked pain, increased
wind-up and heat and cold hyperalgesia [15]. The most
frequent somatosensory abnormalities in terms of loss of
function were observed for nonpainful thermal and
mechanical submodalities in the TMD patients. Hypoal-
gesia to pinprick-evoked pain was detected in 2.9 %
(MPS) of the TMD patients [15]. As the loss/gain system
was not adopted by these previous studies, it is difficult
to compare their results directly with the present study.
Overall, it seems that the present Chinese/East Asian
sample of TMD patients presented similar somatosen-
sory abnormalities as the Caucasian/Western samples of
TMD patients evaluated by same QST protocol, even
though we have previously shown ethnic differences in
somatosensory functions between healthy Chinese and
healthy Caucasians [10].
Somatosensory abnormalities in extra-trigeminal regions
Earlier studies investigating the pain sensitivity of TMD
pain patients in extra-trigeminal regions reported in-
creased experimentally-evoked pain in non-facial areas
[9, 14, 20]. In this study, significant differences between
groups in the extra-trigeminal control site (the dorsum
of the right hand) were also detected, with TMD pain
patients having more frequent somatosensory abnormal-
ities than healthy controls (Additional file 1: Table S4),
and the pattern of these abnormalities was the same as
at the painful sites, but at a lower frequency. The lower
frequency in the hand region may mainly be due to the
lack of consideration of relative abnormalities (Table 3
vs Additional file 1: Table S4). Somatosensory abnormal-
ities in extra-trigeminal region may suggest that central
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mechanisms are involved in the pathophysiology of TMD
pain [7, 21]. It has been suggested that generalized up-
regulation of central responsiveness to aversive stimulation
may constitute a pathophysiological mechanism contribut-
ing to myofascial pain in TMD patients [9, 20]. Disturb-
ance of the endogenous opioid system in TMD pain
patients with myalgia has been suggested, based on a def-
icit in pain inhibition by painful ischemic stimulation [22].
Mechanism-based classification of TMD pain
The pain mechanisms underlying TMD are not fully
understood, which complicates the diagnosis, treatment,
and development of targeted analgesics. For individual
patients, the impairment of joint or muscles, or pain
duration are not consistent with the somatosensory
changes [11], and the phenotype of somatosensory
changes may not always be distinct across different sub-
groups of TMD patients [14]. Treatment strategies could
be improved if quantitative biomarkers could be devel-
oped to phenotype patients with TMD pain in order to
design individualized management. Standardized QST
and statistical procedures (z-transform by individual pa-
tients and the loss/gain coding system) has the potential
to be used for phenotyping TMD pain patients [4, 7, 13].
In a randomized, double-blind, placebo-controlled, and
phenotype-stratified study, 83 peripheral neuropathic pain
patients were tested by the same QST protocol used in the
present study, and patients were grouped into an irritable
nociceptor phenotype and non-irritable nociceptor pheno-
type according to the QST results [23]. The irritable noci-
ceptor phenotype was defined as preserved small-fiber
function (cold, warm, and pinprick sensitivity) together
with hyperalgesia, and the non-irritable nociceptor pheno-
type was defined as deafferentation type, which was
dominated by sensory loss. The results indicated that
oxcarbazepine was more efficacious for relief of peripheral
neuropathic pain in patients with the irritable vs the
non-irritable nociceptor phenotype [23].
The concept of mechanism-based management of TMD
is supported by our data: different patients suffering from
the same clinical disorder presented different phenotypes of
somatosensory abnormalities. The highest rate of abnor-
mality was L0G2 (no somatosensory loss with gain of
mechanical somatosensory function), which is consistent
with Baad-Hansen’s report in atypical odontalgia patients
[18]. In contrast to conventional group comparisons, the
DFNS recommends the approach of allowing clinical judg-
ments on a single-case basis [7, 18]. Given that some TMD
patients show increased, while others show decreased re-
sponses, group mean comparisons could give false-negative
normal values. Somatosensory profiling combining many
QST parameters increases the likelihood of detecting an ab-
normality in any given patient, but also the risk of false-
positive results. Given the increasing patient demand for
cost-effective, evidence-based management of TMD pain,
identifying the characteristics of individual patients is crit-
ical to patient-centered and individualized care.
Limitations of this study
A limitation of this study was the differences in the test
sites between the two groups: the skin overlying the
infraorbital and mental nerve regions for healthy con-
trols, but the painful sites for TMD patients. However,
the DFNS has similarly used data from the hand region
to represent the upper body and data from the foot re-
gion to represent the lower body, and we suggest the ref-
erence material in this study to be equally appropriate
[4, 7]. Another limitation could be that the sample size
of the healthy controls did not allow for extensive age-
stratification related to somatosensory changes. Due to
the small sample size in each group, myalgia and arthral-
gia patients were evaluated as one group for this ex-
ploratory analysis. These need to be improved in future
multicenter studies.
Conclusions
This is the first study using the full battery of QST tests
and statistical protocol recommended by the German Re-
search Network on Neuropathic Pain in the orofacial re-
gion, to assess the somatosensory function of Chinese
patients with painful temporomandibular disorders and
Chinese healthy controls. Furthermore, the TMD diagnoses
were based on a validated and reproducible diagnostic sys-
tem (DC/TMD). Somatosensory abnormalities were de-
tected in 82.5 % for painful sites and 60.0 % for the extra-
trigeminal site in TMD pain patients, most frequently in
the form of somatosensory gain to nociceptive mechanical
stimuli for both regions, suggesting a more generalized
sensitization in the patients. TMD pain patients presented
differences in somatosensory profiles, which may support
the concept of individualized pain mechanisms-based
management.
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